Filters

Model Canvas

Edges coloured by evidence tier. Click an edge for parameter detail. Hydrated from the active cohort, with trial readouts and expert priors filling the gaps.

Model canvas

A · RWE-calibrated· 12B · Trial / partial RWE· 18C · Guideline / assumption· 20D · Expert prior · gap· 10
A · RWEB · TrialC · AssumptionD · Gap
DIAGNOSIS1L2L · CO-MORBIDITY3L+OUTCOME62% · n=68628% · n=31055% · n=26020% · n=9540% · n=4225% · n=2620% · n=2145% · n=12532% · n=8923% · n=6430% · n=1140% · n=1530% · n=1135% · n=34655% · n=54345% · n=18220% · n=8135% · n=14262% · n=15320% · n=4925% · n=3145% · n=5630% · n=3830% · n=7120% · n=4750% · n=11855% · n=3935% · n=2560% · n=2820% · n=920% · n=11665% · n=37870% · n=9725% · n=1945% · n=3430% · n=040% · n=030% · n=055% · n=1035% · n=745% · n=6240% · n=5560% · n=1730% · n=9ISM-lowINDEXn=1,107ISM-highINDEXn=473SSMINDEXn=104AdvSMINDEXn=278MCLINDEXn=381L Anti-mediatorTREATMENTn=9881L Antihistamine onlyTREATMENTn=4051L AvapritinibTREATMENTn=2471L MidostaurinTREATMENTn=1251L Untreated / sx-onlyTREATMENTn=2352L Add-on (LTRA / cromolyn)TREATMENTn=5812L OmalizumabTREATMENTn=1382L Switch TKI (mido↔ava)TREATMENTn=752L CytoreductiveTREATMENTn=0Anaphylaxis / EDCOMORBIDITYn=71GI flareCOMORBIDITYn=473L+ CytoreductiveTREATMENTn=193L+ CombinationTREATMENTn=137Clinical trialTREATMENTn=29Stable / maintainedTERMINALn=1,484ProgressionTERMINALn=172DiscontinuedTERMINALn=316Death proxyTERMINALn=31
Flow legend
Color = evidence tier
ABCD
Density = transition strength
Tier D edges are dashed and pulse faintly to flag gaps.
Click any edge to inspect its parameters and evidence trace.